설명

Pharmacokinetic advantages of probiotic-fermented herbal extracts versus unfermented preparations. Enhanced oral bioavailability, metabolic stability, and tissue distribution of fermented compounds are summarized.

Figure 18

Diagram

Source Paper

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.

International journal of molecular sciences (2025)

PMID: 40564947

DOI: 10.3390/ijms26125486

Cite This Figure

![Figure 18: Pharmacokinetic advantages of probiotic-fermented herbal extracts versus unfermented preparations. Enhanced oral bioavailability, metabolic stability, and tissue distribution of fermented compounds are summarized.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="Pharmacokinetic advantages of probiotic-fermented herbal extracts versus unfermented preparations. Enhanced oral bioavailability, metabolic stability, and tissue distribution of fermented compounds are summarized." />
  <figcaption>Figure 18. Pharmacokinetic advantages of probiotic-fermented herbal extracts versus unfermented preparations. Enhanced oral bioavailability, metabolic stability, and tissue distribution of fermented compounds are summarized.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>

설명

Figure 18

Source Paper

Cite This Figure

관련 근거